Therapeutic Area
Peripheral Artery Disease Clinical Trials — Amavita Research
Cardiovascular trial site for peripheral artery disease, conducted at amavita Heart and Vascular Health® in North Miami Beach, FL.
Peripheral artery disease affects roughly 8.5 million U.S. adults over age 40 and is dramatically under-diagnosed. The device pipeline is active in atherectomy, drug-coated balloons, and below-the-knee intervention for chronic limb-threatening ischemia. Here is what Amavita Research is currently running in this space.
Active trials at Amavita Research
- GREAT — Golazo® Peripheral Atherectomy System
Sponsor: Avantec Vascular · Pivotal
The GREAT Trial evaluates the Golazo® Peripheral Atherectomy System for safe and effective atherectomy in patients with peripheral artery disease. Phase: device IDE study.
Principal Investigators in this area
Why Amavita Research for peripheral artery disease trials
- Dr. Pedro Martinez-Clark, MD, FACC as PI — interventional cardiologist with peripheral atherectomy experience.
- Active pivotal enrollment on the GREAT trial (Avantec Vascular Golazo® peripheral atherectomy system).
- Below-the-knee intervention capability via the affiliated Advanced Cardiovascular of Miami ambulatory surgical center.
- Procedure suite supports IVUS, OCT, peripheral angiography, and structured post-procedure follow-up per ICH-GCP E6(R3).
- Dedicated PAD patient flow from the parent cardiology practice's vascular clinic.
Think you might be eligible for a peripheral artery disease trial?
Call (786) 703-5941 or use the patient contact form — initial screening is free and takes about 15 minutes.